| 7.7 |
46.5 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 6.8 |
20.4 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 6.6 |
19.9 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 5.7 |
11.4 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 5.5 |
16.4 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 4.9 |
29.5 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 4.8 |
24.0 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 4.1 |
12.2 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 3.9 |
19.7 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 3.8 |
7.7 |
GO:1905065 |
positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 3.8 |
11.3 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 3.6 |
36.1 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 3.6 |
17.9 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 3.0 |
9.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 2.9 |
11.6 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 2.8 |
8.5 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 2.8 |
11.2 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 2.8 |
27.6 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 2.8 |
8.3 |
GO:0035910 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 2.7 |
13.4 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) |
| 2.7 |
8.0 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 2.7 |
5.3 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 2.6 |
7.9 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 2.6 |
10.3 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 2.5 |
25.1 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 2.5 |
7.4 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 2.4 |
14.6 |
GO:1902847 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) |
| 2.4 |
9.5 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 2.2 |
8.9 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 2.2 |
10.9 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 2.1 |
12.8 |
GO:0060737 |
prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 2.1 |
12.7 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 2.1 |
4.1 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 2.1 |
8.2 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 2.0 |
6.1 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 2.0 |
7.9 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 2.0 |
5.9 |
GO:0008228 |
opsonization(GO:0008228) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 1.9 |
5.8 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 1.9 |
3.7 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
| 1.9 |
5.6 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 1.8 |
3.6 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 1.7 |
5.0 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 1.7 |
5.0 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 1.6 |
18.1 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 1.6 |
13.0 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 1.6 |
9.6 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 1.6 |
4.8 |
GO:1902524 |
negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 1.6 |
7.9 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 1.6 |
10.9 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 1.5 |
7.6 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 1.4 |
7.2 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 1.4 |
4.3 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 1.4 |
6.9 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 1.4 |
1.4 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 1.3 |
8.8 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.2 |
6.2 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 1.2 |
9.6 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 1.2 |
3.6 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.2 |
4.8 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 1.2 |
7.1 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 1.2 |
4.7 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 1.1 |
4.6 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 1.1 |
5.7 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 1.1 |
5.4 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 1.0 |
3.1 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 1.0 |
6.1 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 1.0 |
3.0 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 1.0 |
2.0 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 1.0 |
3.0 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 1.0 |
4.0 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 1.0 |
4.0 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 1.0 |
1.0 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.0 |
3.0 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 1.0 |
12.6 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 1.0 |
2.9 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.9 |
2.8 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.9 |
1.9 |
GO:2000468 |
regulation of peroxidase activity(GO:2000468) |
| 0.9 |
8.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.9 |
6.3 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.9 |
8.9 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.9 |
14.6 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.9 |
4.3 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.9 |
8.6 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.8 |
12.6 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.8 |
6.7 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.8 |
3.3 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.8 |
2.5 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.8 |
13.0 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.8 |
3.3 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.8 |
4.0 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.8 |
2.4 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.8 |
0.8 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.8 |
1.5 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.8 |
3.8 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.8 |
3.0 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.7 |
3.7 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.7 |
3.0 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.7 |
2.2 |
GO:1905154 |
negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
| 0.7 |
2.1 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.7 |
5.0 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.7 |
2.1 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.7 |
8.2 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.7 |
18.2 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.7 |
18.3 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.6 |
4.5 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.6 |
5.1 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.6 |
1.9 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
| 0.6 |
5.4 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.6 |
2.4 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.6 |
3.6 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.6 |
1.8 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.6 |
3.4 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.6 |
13.1 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.6 |
1.7 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.6 |
1.7 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.6 |
1.1 |
GO:0010873 |
positive regulation of cholesterol esterification(GO:0010873) |
| 0.5 |
1.6 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.5 |
3.3 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.5 |
2.2 |
GO:0050857 |
positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
| 0.5 |
9.7 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.5 |
9.5 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.5 |
19.7 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.5 |
10.7 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.5 |
4.0 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.5 |
9.0 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.5 |
3.5 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.5 |
3.9 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.5 |
5.8 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.5 |
7.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.5 |
3.3 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.5 |
0.9 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.5 |
1.4 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.5 |
1.4 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.5 |
7.3 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.5 |
4.5 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.5 |
5.0 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 |
4.0 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.4 |
2.2 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.4 |
5.3 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.4 |
4.4 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.4 |
1.7 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.4 |
6.5 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.4 |
1.3 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.4 |
1.7 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.4 |
4.1 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.4 |
1.2 |
GO:1903546 |
receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
| 0.4 |
3.4 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.4 |
14.3 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.4 |
1.8 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.4 |
1.4 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.4 |
8.9 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.3 |
2.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.3 |
2.7 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.3 |
2.7 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.3 |
0.7 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.3 |
4.0 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.3 |
0.3 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.3 |
3.6 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.3 |
3.6 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.3 |
1.6 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) otic vesicle morphogenesis(GO:0071600) regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.3 |
5.0 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.3 |
1.5 |
GO:0021984 |
adenohypophysis development(GO:0021984) |
| 0.3 |
2.4 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.3 |
1.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.3 |
1.7 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.3 |
0.9 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.3 |
3.7 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.3 |
3.1 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.3 |
3.0 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) positive regulation of stem cell population maintenance(GO:1902459) |
| 0.3 |
3.3 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.3 |
3.5 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.3 |
4.3 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.3 |
2.7 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.3 |
4.0 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.3 |
7.1 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.3 |
7.2 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.3 |
2.5 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.3 |
3.0 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.2 |
0.7 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 |
0.7 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.2 |
0.7 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.2 |
8.5 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.2 |
0.7 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.2 |
0.7 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 |
2.4 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
6.5 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.2 |
3.3 |
GO:0007063 |
regulation of sister chromatid cohesion(GO:0007063) |
| 0.2 |
1.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.2 |
1.8 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.2 |
2.2 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.2 |
1.0 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.2 |
6.7 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.2 |
1.0 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.2 |
0.6 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.2 |
0.7 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.2 |
1.1 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.2 |
10.4 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.2 |
0.9 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.2 |
1.3 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.2 |
0.4 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.2 |
3.4 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.2 |
1.2 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.2 |
4.2 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
0.5 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.2 |
4.6 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.2 |
0.3 |
GO:1903596 |
regulation of gap junction assembly(GO:1903596) |
| 0.2 |
0.7 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 |
1.8 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.2 |
1.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
1.0 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.2 |
0.5 |
GO:0050929 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) response to heparin(GO:0071503) cellular response to heparin(GO:0071504) negative regulation of mononuclear cell migration(GO:0071676) regulation of retinal ganglion cell axon guidance(GO:0090259) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.2 |
2.4 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
3.4 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.1 |
0.4 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.1 |
1.6 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.1 |
2.7 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
4.7 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.1 |
0.7 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
2.8 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
0.8 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 |
0.5 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
2.3 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.1 |
2.5 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
1.3 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 |
1.5 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
0.5 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
1.3 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
6.7 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
1.0 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.1 |
3.1 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
2.0 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
1.1 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
1.2 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.1 |
0.6 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
2.4 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.1 |
3.3 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.1 |
0.9 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
3.7 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.7 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.1 |
0.8 |
GO:0009186 |
deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.1 |
1.7 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.1 |
1.4 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.7 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.4 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
1.4 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.1 |
3.0 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.1 |
0.4 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 |
0.4 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
0.6 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.1 |
0.4 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.1 |
0.1 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.1 |
0.3 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
| 0.1 |
0.9 |
GO:0051321 |
meiotic cell cycle(GO:0051321) |
| 0.1 |
0.6 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
0.6 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.2 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
4.2 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.1 |
1.7 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.1 |
0.5 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
| 0.1 |
2.5 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
6.1 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.1 |
0.3 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
3.3 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.1 |
0.4 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
0.6 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.1 |
0.1 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.1 |
1.5 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.1 |
3.5 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.1 |
0.5 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.3 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.3 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
0.4 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.6 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
5.6 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.1 |
0.6 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.1 |
3.2 |
GO:0043507 |
positive regulation of JUN kinase activity(GO:0043507) |
| 0.1 |
2.4 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.1 |
6.5 |
GO:0043123 |
positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.1 |
0.7 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
2.7 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.1 |
0.4 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) asymmetric neuroblast division(GO:0055059) |
| 0.1 |
0.2 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 |
0.4 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.5 |
GO:2000780 |
negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.1 |
5.9 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.1 |
1.0 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) peptidyl-proline modification(GO:0018208) |
| 0.1 |
0.4 |
GO:0017144 |
drug metabolic process(GO:0017144) |
| 0.1 |
1.3 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
1.3 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.0 |
1.1 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.0 |
2.0 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 |
1.6 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.6 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 |
0.2 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.5 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
4.9 |
GO:0007160 |
cell-matrix adhesion(GO:0007160) |
| 0.0 |
0.5 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
1.3 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
1.5 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
0.2 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
0.4 |
GO:2000480 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.2 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.6 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.1 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.0 |
0.6 |
GO:0009142 |
nucleoside triphosphate biosynthetic process(GO:0009142) |
| 0.0 |
2.9 |
GO:0008203 |
cholesterol metabolic process(GO:0008203) |
| 0.0 |
2.7 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
1.1 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.6 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.0 |
0.4 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 |
0.3 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.2 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.0 |
0.5 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.0 |
0.2 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.0 |
0.8 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.2 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.1 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.1 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.0 |
0.5 |
GO:0031102 |
neuron projection regeneration(GO:0031102) |
| 0.0 |
0.2 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 |
1.2 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.2 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 |
0.5 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.5 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 |
0.2 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.1 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.0 |
0.5 |
GO:0035195 |
gene silencing by miRNA(GO:0035195) |
| 0.0 |
1.7 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.0 |
1.0 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.1 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 |
0.0 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.0 |
2.2 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
